Press release
Digital Therapeutics (DTX) To Accelerate the Sickle Cell Disease Treatment Market
Global sickle cell disease treatment market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing adoption of therapies, growing awareness regarding the sickle cell disease treatment in MEA region. “Sickle Cell Disease Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” is the new report published by Persistence Market Research for the projected period of 8-years, i.e. 2017-2025.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/16099
Company Profiles
AstraZeneca Plc.
Eli Lilly and Company
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc.
Baxter International Inc.
Emmaus Life Sciences, Inc.
Bluebird bio, Inc.
Global Blood Therapeutics Inc.
Sangamo Therapeutics, Inc.
Acceleron Pharma, Inc.
Arena Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Others.
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
According to this report, the global sickle cell disease treatment market is projected to expand at a CAGR of 6.0 % in terms of value during the forecast period to reach US$ 584.0 Mn by 2025. There is an increased opportunity of the development of the global sickle cell disease treatment market due to drug approvals and drugs in the pipeline which are expected to enter the market in the coming five years.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/16099
Global Sickle Cell Disease Treatment Market: Drivers
Increasing discretionary research funding for Sickle cell anaemia in developed countries
Governments focus on creating awareness on sickle cell anemia cure
Aging population in developed economies and rising affluence in emerging markets to boost healthcare spending
Demand for drug therapy in combination with surgeries and blood transfusion
Changes in lifestyle to increase the probability of genomic mutations
Increasing penetration of FDA approved drugs in the market
Various key players in the sickle cell disease treatment market are signing partnerships and licensing deals to share the research and development platform
Reduction of overall diagnosis cost for sickle cell diseases
Global Sickle Cell Disease Treatment Market: Forecast by Drug Type
On the basis of drug type, the global sickle cell disease treatment market is segmented into hydroxyurea, antibiotics, pain-relieving medications, and Others.
The hydroxyurea segment is likely to be accounted for 38.7 % market revenue share in 2017, which is expected to increase to 35.7% by 2025 end. This drug type is expected to account for a high revenue contribution in the global sickle cell disease treatment market as compared to other drug types over the forecast period.
Hydroxyurea product is expected to be the second attractive drug type segment in sickle cell disease treatment market, with market attractiveness index of 1.2.
Global Sickle Cell Disease Treatment Market: Forecast by Disease Type
On the basis of disease type, the global sickle cell disease treatment market is segmented into sickle cell anemia, sickle hemoglobin C disease, and sickle beta thalassemia. Sickle cell anemia is expected to be the most lucrative among all disease type segment of sickle cell disease treatment market, with attractiveness index of 1.8.
Sickle Beta Thalassemia is expected to be the second attractive drug type segment in sickle cell disease treatment market, with market attractiveness index of 0.7.
Global Sickle Cell Disease Treatment Market: Forecast by Distribution Channel
This segment include hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to witness a significant rise in revenue share over the forecast period, owing to the increasing direct procurement of drugs by governments to ensure availability in hospital pharmacies.
Hospital pharmacies is expected to be the most lucrative among all distribution channels of sickle cell disease treatment market, with attractiveness index of 2.5. Retail pharmacies is expected to be the second largest distribution channels of sickle cell disease treatment market, with market attractiveness index of 0.4
Access Full Report @ https://www.persistencemarketresearch.com/checkout/16099
Global Sickle Cell Disease Treatment Market: Forecast by Region
Five regions such as North America, Latin America, Europe, APAC and MEA are covered in this report. MEA regions are pegged to represent the most lucrative markets, owing to the high prevalent cases of sickle cell diseases.
The MEA sickle cell disease treatment market is expected to expand at a CAGR of 6.1 % in terms of value over the forecast period. Growing awareness and adoption of treatment for sickle cell disease in India and in the APAC region is expected to create a sizeable opportunity for the players in this market.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/sickle-cell-disease-treatment-market.asp
Read More Trending "PMR Exclusive Article"-
Cosmetic Procedures Market@ https://www.persistencemarketresearch.com/market-research/cosmetic-procedures-market.asp
Allergic Rhinitis Market@ https://www.persistencemarketresearch.com/market-research/allergic-rhinitis-market.asp
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Therapeutics (DTX) To Accelerate the Sickle Cell Disease Treatment Market here
News-ID: 2550764 • Views: …
More Releases from Persistence Market Research
Centrifugal Pumps Market Set to Reach US$ 55.7 Billion by 2032, Insights from Pe …
The global centrifugal pumps market is poised for significant expansion, with the market projected to grow from US$ 41.2 billion in 2025 to reach US$ 55.7 billion by 2032, reflecting a CAGR of 4.4%. The growth is primarily fueled by increasing demand for efficient water management solutions across agriculture, industrial manufacturing, and municipal services. Centrifugal pumps play a crucial role in ensuring seamless fluid transfer, reducing energy consumption, and maintaining…
CAR T-cell Therapy Market to Touch US$24 Billion by 2032, Reports Persistence Ma …
The global CAR T-cell therapy market is experiencing transformative growth, projected to expand from an estimated US$5.8 billion in 2025 to US$24 billion by 2032, reflecting a compound annual growth rate (CAGR) of 25% during the forecast period from 2025 to 2032. This growth trajectory is being driven by a confluence of factors, including rising cancer prevalence, especially hematologic malignancies, and continuous advancements in gene-editing technologies and immunotherapy. As these…
Hydraulic Fluid Connector Market Technological Innovations, Efficiency Drivers, …
Hydraulic fluid connectors are used only in fluid power and piping systems for efficient operation in industrial fluid networks. A hydraulic fluid connector is deployed in these systems to increase the total machine performance irrespective of applications. Hydraulic fluid connectors are used to enhance uptime in the remote applications such as oil and gas drilling, pipeline installation and mining.
Innovations in the offering of tearout-proof technology for hydraulic…
Facial Aesthetics Market Poised for 11.8% CAGR Growth through 2032, Says Persist …
The global facial aesthetics market is on a trajectory of robust growth. Valued at approximately US$17.15 billion in 2025, it is projected to reach US$37.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.8% during the forecast period from 2025 to 2032. This expansion is primarily driven by the growing preference for minimally invasive procedures such as botulinum toxins (botox) and dermal fillers, especially as consumers…
More Releases for Sickle
Sickle Cell Disease Treatment Market - Improving Quality of Life: Pioneering Sic …
Newark, New Castle, USA: The "Sickle Cell Disease Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Sickle Cell Disease Treatment Market: https://www.growthplusreports.com/report/sickle-cell-disease-treatment-market/7808
This latest report researches the…
Sickle Cell Disease Treatment Market - Breaking the Chains of Sickle Cell: Pione …
Newark, New Castle, USA - new report, titled Sickle Cell Disease Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sickle Cell Disease Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sickle Cell Disease Treatment market. The report offers…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market is a segment of the broader pharmaceutical industry that is focused on developing treatments for sickle cell disease, a genetic disorder that affects the red blood cells. In 2022, the sickle cell disease treatment market is expected to continue to grow, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be worth billions of…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the healthcare industry that produces and markets treatments for sickle cell disease (SCD), a genetic disorder that affects the production of hemoglobin in red blood cells. SCD can cause various complications, including pain, infections, and organ damage, and there is currently no cure for the disease. However, various treatments are available that can help manage the symptoms and improve…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the pharmaceuticals industry that deals with the production and sales of treatments for sickle cell disease. Sickle cell disease is a genetic blood disorder that causes red blood cells to become misshapen and form a sickle shape. This can lead to a range of complications, including anemia, chronic pain, and increased risk of infections.
The market for sickle cell disease…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The Sickle Cell Disease Treatment Market is an emerging segment in the healthcare industry. This debilitating disorder affects millions of people around the world, with no known cure available. However, recent advances in research have improved the treatment options for those suffering from sickle cell disease. The Sickle Cell Disease Treatment Market is expected to experience significant growth over the coming years as treatments become more effective and accessible. Several…
